Market Overview The global clinical nutrition market is expected to witness a CAGR of 6.0%. There are certain factors propelling the growth of the market that includes the increasing prevalence of metabolic disorders, high spending on healthcare and the rise of the middle class in emerging economies.
Over the past decade, the prevalence of metabolic disorders has increased, in terms of raw data. The actual number of patients opting for the diagnosis of metabolic disorders has increased over the last decade, thereby resulting in an increase in the number of patients diagnosed. Thus, with the rising prevalence of metabolic diseases, there is a great opportunity for market players to tap the emerging markets and establish their presence.
It has also been observed that healthcare expenditure continues to grow faster than economic growth in most of the countries, maintaining a trend observed over the decades. Therefore, as healthcare spending increases among major countries of the world, because of its wide applicability, the market is expected to witness high growth.
There are many funding opportunities for clinical nutrition from governments across the globe, including private foundations and the international community. The major funding organizations are - National Institutes of Health, US Department of Agriculture, Robert Woods Johnson Foundation, and Nestle Foundation. These funding opportunities are found propelling the growth of the market.
Scope of the Report Clinical malnutrition is a disease condition that can be treated only with clinical intervention, through the use of specialized nutrients that are considered as proper medications, rather than as supplements. Clinical nutrition products thus help to keep the patient healthy and aids to improve the metabolic system of the body by providing adequate supplements such as minerals, vitamins, and others. Additionally, the high birth rate and a higher number of premature births also demand advanced clinical nutrition.
Key Market Trends Oral and Enteral is Expected to Show the Fastest Growth in the Route of Administration
The oral and enteral route of administration accounts for the largest share as they are used the most, followed by a parenteral route. This is mainly because of the additional cost of processing the product/nutrient involved in enteral/parenteral routes.
Therefore like the other routes of administration, physicians also prefer mostly the oral route, as it involves lesser complexities and costs, compared to the other two routes of administration. In addition, in most of the disease conditions like chronic conditions and not acute conditions, the oral route is being preferred thereby driving the overall market.
Asia-Pacific holds the Fastest Growth and is Expected to Follow the Same Trend over the Forecast Period
Asia-Pacific has the highest growth in comparison to the other regions in the forecast period mainly due to high levels of malnutrition, and the presence of severe chronic diseases, in the region. Thus due to the increased metabolic disorders and rising income inequality in various countries, the region is also expected to witness robust growth over the forecast period.
Competitive Landscape The industry players are found focusing on expansion through various inorganic strategies such as acquisition, merger, strategic collaboration, and others to gain significant market share and to strengthen their product portfolios. Thus the growing awareness about clinical nutrition has boosted the demand for pediatric, as well as adult nutrition formulae.
Reasons to Purchase this report: - The market estimate (ME) sheet in Excel format - Report customization as per the client’s requirements - 3 months of analyst support
Our reports have been used by over 10K customers, including:
The global empty capsules market is projected to reach USD 3.7 billion by 2026 from USD 2.6 billion in 2021, at a CAGR of 7.2% during the forecast period. The overall growth of the empty capsules market is largely driven by the growing adoption of capsule formulations among the growing geriatric population, the growth of the pharmaceutical...
The market size of microcapsule is estimated at USD 8.4 billion in 2021 and is projected to reach USD 13.4 billion by 2026, at a CAGR of 9.8% from 2021 to 2026. The microcapsule market is on course for intense growth across different end-user industry verticals such as pharmaceuticals & healthcare, food, household & personal care, textiles,...
The global injectables market is estimated to reach US$759.61 billion in 2025, progressing at a CAGR of 10.95%, over the period 2021-2025. Factors such as increasing geriatric population, upsurge in demand for convenient drug delivery, expanding use of biologics, rising healthcare expenditure and surging incidence of cancer cases would drive...
The ePRO, epatient diaries, and eCOA market was valued at US$ 1,342.92 million in 2020 and it is projected to reach US$ 4,130.35 million by 2028; it is expected to grow at a CAGR of 15.08% during 2020-2028. Increasing demand for electronic health records (EHRs) and rising use of smartphones are fueling the market growth. However, concerns...
Anesthesia is one of the most essential components for any surgical procedure. It induces temporary unconsciousness and loss of protective reflexes. According to the Centers for Disease Control and Prevention (CDC), more than 51 million inpatient surgeries and 53 million outpatient surgeries were performed in the United States in 2017, with...
The Transdermal Skin Patches market is expected to register a CAGR of about 4.78% during the forecast period with a revenue of approximately USD 7244.33 million in 2020 and expected to reach USD 9572.34 million by 2026. The COVID-19 outbreak across the world is expected to have a positive impact on the transdermal skin patches market,...
The onychomycosis market estimated to be valued at USD USD 2730.72 million in 2020 and is expected to reach approximately USD 3781.42 million in 2026, registering a CAGR of nearly 5.75% during the forecast period. Prior to the COVID-19 pandemic, clinical examination, dermoscopy, and mycological examination were recommended for all patients...
Germany - Healthcare, Regulatory and Reimbursement Landscape
The analyst has released its latest report, "Germany - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape...
Norway - Healthcare, Regulatory and Reimbursement Landscape
The analyst has released its latest report, "Norway - Healthcare, Regulatory and Reimbursement Landscape".The report is an essential source of information on analysis of healthcare, regulatory, and reimbursement landscape in Norway.
The Veterinary Pain management market was valued at USD 1,197 million in 2020, and it is expected to reach USD 1,910 million in 2026, registering a CAGR of nearly 6.30% during the forecast period. The global outbreak of COVID-19 has impacted all industries including veterinary pain medicine. Pet parents are advised to keep a safe distance...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.